1975
DOI: 10.1016/0002-8703(75)90430-5
|View full text |Cite
|
Sign up to set email alerts
|

Reversibility of left ventricular asynergy by nitroglycerin in coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1982
1982
2014
2014

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Lesser improvement or deterioration of LVEF after TAVI in patients with incomplete revascularization may have different explanations including active coronary ischemia and non‐viable myocardium which are well established determinants of low LVEF as well as the fact that non‐revascularized CAD might result in a lesser degree of left ventricle hypertrophy regression and therefore diminished left ventricle reverse remodeling . Indeed, extensive left ventricular remodeling has been shown to be associated with impaired LVEF recovery despite the presence of viability .…”
Section: Discussionmentioning
confidence: 99%
“…Lesser improvement or deterioration of LVEF after TAVI in patients with incomplete revascularization may have different explanations including active coronary ischemia and non‐viable myocardium which are well established determinants of low LVEF as well as the fact that non‐revascularized CAD might result in a lesser degree of left ventricle hypertrophy regression and therefore diminished left ventricle reverse remodeling . Indeed, extensive left ventricular remodeling has been shown to be associated with impaired LVEF recovery despite the presence of viability .…”
Section: Discussionmentioning
confidence: 99%
“…Different markers of myocardial viability have been established: (a) functional improvement with post-extrasystolic potentiation (10,18,22,41) after the administration of nitroglycerin (8,9,23,31,42) or under catecholamine stimulation (1,10,26), (b) preserved enddiastolic wall thickness and systolic wall thickening (4,6,7,28,45,46,53) as well as (c) preserved F-18 deoxyglucose util-ization or mismatch between metabolism and perfusion on positron emission tomography (PET) (13,50,52).…”
Section: Zusammenfassungmentioning
confidence: 99%